Sarepta Therapeutics, Inc. SRPT Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Sarepta Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s quick ratio?
- Sarepta Therapeutics, Inc. (SRPT) reported quick ratio of 4.3× in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s quick ratio changed year-over-year?
- Sarepta Therapeutics, Inc.'s quick ratio increased by 15.0% year-over-year, from 3.7× to 4.3×.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s quick ratio has grown at a -16.9% compound annual growth rate (CAGR), from 5.4× to 2.1×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.